Literature DB >> 24385022

Ileal exclusion in children with progressive familial intrahepatic cholestasis.

Irena Jankowska1, Piotr Czubkowski, Piotr Kaliciński, Hor Ismail, Adam Kowalski, Józef Ryżko, Joanna Pawłowska.   

Abstract

OBJECTIVES: Children with progressive familial intrahepatic cholestasis (PFIC) rarely benefit from medical treatment and most patients require surgical intervention. Partial external biliary diversion (PEBD) is presently the treatment of choice but for those who cannot benefit from PEBD, an alternative surgical procedure--ileal exclusion (IE)--was introduced. The aim of this study was to analyze our experience with IE in children with PFIC.
METHODS: This procedure was performed in 9 patients (6 girls, 3 boys) at the median age of 11 years (range 8-21). In 4 children, it was the primary operation (group 1), and in 5, IE was performed after PEBD (group 2). All of the patients were screened for ABCB11 and ATP8B1 mutations, and in 3 cases, PFIC type 2 was confirmed.
RESULTS: Median follow-up after IE surgery was 8.5 years (range 3-14). In group 1, 1 patient had to be converted to PEBD and the remaining 3 children experienced alleviation in pruritus and decrease in bilirubin and bile acids concentrations 2 and 5 years after IE. After 10 years, only 2 children were still accessible for follow-up. In both, pruritus varied and elevated serum bile acids were observed. Of the 5 patients who underwent IE after PEBD, 1 eventually required liver transplantation, 1 developed varying degree of pruritus, and 3 female patients, operated on because of aesthetic reasons, had excellent outcomes.
CONCLUSIONS: IE is an alternative rescue option to PEBD and should be offered cautiously, only to patients who cannot benefit from PEBD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24385022     DOI: 10.1097/MPG.0b013e3182a9097c

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Outcome of partial internal biliary diversion for intractable pruritus in children with cholestatic liver disease.

Authors:  P Ramachandran; N P Shanmugam; S Al Sinani; V Shanmugam; S Srinivas; M Sathiyasekaran; V Tamilvanan; M Rela
Journal:  Pediatr Surg Int       Date:  2014-07-27       Impact factor: 1.827

2.  Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis.

Authors:  Kasper S Wang; Greg Tiao; Lee M Bass; Paula M Hertel; Douglas Mogul; Nanda Kerkar; Matthew Clifton; Colleen Azen; Laura Bull; Philip Rosenthal; Dylan Stewart; Riccardo Superina; Ronen Arnon; Molly Bozic; Mary L Brandt; Patrick A Dillon; Annie Fecteau; Kishore Iyer; Binita Kamath; Saul Karpen; Frederick Karrer; Kathleen M Loomes; Cara Mack; Peter Mattei; Alexander Miethke; Kyle Soltys; Yumirle P Turmelle; Karen West; Jessica Zagory; Cat Goodhue; Benjamin L Shneider
Journal:  Hepatology       Date:  2017-03-22       Impact factor: 17.425

3.  A Report of 2 Infant Siblings with Progressive Intrahepatic Familial Cholestasis Type 1 and a Novel Homozygous Mutation in the ATP8B1 Gene Treated with Partial External Biliary Diversion and Liver Transplant.

Authors:  Irena Jankowska; Joanna Pawłowska; Marek Szymczak; Hor Ismail; Dorota Broniszczak; Joanna Cielecka-Kuszyk; Piotr Socha; Dorota Jarzębicka; Piotr Czubkowski
Journal:  Am J Case Rep       Date:  2021-07-20

Review 4.  Current and future therapies for inherited cholestatic liver diseases.

Authors:  Wendy L van der Woerd; Roderick Hj Houwen; Stan Fj van de Graaf
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

Review 5.  Epidemiology and burden of progressive familial intrahepatic cholestasis: a systematic review.

Authors:  Tracey Jones-Hughes; Jo Campbell; Louise Crathorne
Journal:  Orphanet J Rare Dis       Date:  2021-06-03       Impact factor: 4.123

6.  Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies.

Authors:  Laura N Bull; Ludmila Pawlikowska; Sandra Strautnieks; Irena Jankowska; Piotr Czubkowski; Jennifer L Dodge; Karan Emerick; Catherine Wanty; Sami Wali; Samra Blanchard; Florence Lacaille; Jane A Byrne; Albertien M van Eerde; Kaija-Leena Kolho; Roderick Houwen; Steven Lobritto; Vera Hupertz; Patricia McClean; Giorgina Mieli-Vergani; Etienne Sokal; Philip Rosenthal; Peter F Whitington; Joanna Pawlowska; Richard J Thompson
Journal:  Hepatol Commun       Date:  2018-03-30

Review 7.  Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.

Authors:  Huey-Ling Chen; Shang-Hsin Wu; Shu-Hao Hsu; Bang-Yu Liou; Hui-Ling Chen; Mei-Hwei Chang
Journal:  J Biomed Sci       Date:  2018-10-26       Impact factor: 8.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.